In June of 2024, the Endocrine Society, influenced by a substantial body of research conducted in recent years, published new clinical practice guidelines for the testing and supplementation of Vitamin D for the prevention of disease. These new recommendations included limiting vitamin D supplementation beyond the daily recommended intake to specific risk groups and advised against routine 25-hydroxyvitamin D [25(OH)D] testing in healthy individuals.